IP Library Granted Patent US 7,202,053
Granted Patent B2
US 7,202,053 · App. 10/850,102 · Granted Apr 10, 2007

Mitogenic oxygenase regulators

Assignee: Emory University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,053
App. No.
10/850,102
Granted
Apr 10, 2007
Kind
B2
Abstract

The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.

Claims (11)

1. A method of determining the activity of an agent to decrease cell division, comprising contacting a protein comprising the amino acid sequence of SEQ ID NO:4, or a fragment of SEQ ID NO: 4 capable of superoxide production, or a substitution thereof of less than 1% of the amino acid sequence, with the agent; and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein as compared to a control not contacted with the agent, thereby determining the ability of the agent to decrease cell division.

2. The method of claim 1 , wherein the protein comprises the amino acid sequence of SEQ ID NO:4 or a fragment of SEQ ID NO: 4 capable of superoxide production.

3. The method of claim 1 , wherein the method comprises measuring the ability of the agent to inhibit superoxide production.

4. The method of claim 1 , wherein the method comprises measuring the ability of the agent to bind the protein.

5. The method of claim 1 , wherein the protein comprises the C-terminal 265 amino acids of SEQ ID NO: 4.

6. The method of claim 1 , wherein the method comprises measuring the ability of the agent to inhibit diaphorase activity.

7. The method of claim 6 , wherein measuring the ability of the agent to inhibit the diaphorase activity comprises evaluating NAPDH-dependent reductase activity.

8. The method of claim 6 , wherein evaluating the diaphorase activity of the protein comprises use of cytochrome c or nitrobluetetrazolium.

9. A method for identifying an agent that modulates the activity of a Nox enzyme, comprising contacting an agent of interest with a protein comprising the C-terminal 265 amino acids of SEQ ID NO: 4 capable of superoxide production; and evaluating the diaphorase activity of the protein; wherein a decrease in the diaphorase activity of the protein as compared to a control indicates that the agent modulates the activity of a Nox enzyme.

10. The method of claim 9 , wherein evaluating the diaphorase activity of the protein comprises evaluating NAPDH-dependent reductase activity.

11. The method of claim 9 , wherein evaluating the diaphorase activity of the protein comprises use of cytochrorue c or nitrobluetetrazolium.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 28, 2012
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029050/0877 →
Continuity (6)
Division 0999924800 · Nov 15, 2001
Provisional Application 6028917200 · May 7, 2001
Provisional Application 6028953700 · May 7, 2001
Provisional Application 6025136400 · Dec 5, 2000
Provisional Application 6024930500 · Nov 16, 2000
Related Publication 20050202452A1 · Sep 15, 2005